ID: ALA4760059

Max Phase: Preclinical

Molecular Formula: C22H36O3

Molecular Weight: 348.53

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCCCCCCCCCCCCCCc1cccc(C(=O)O)c1O

Standard InChI:  InChI=1S/C22H36O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-16-19-17-15-18-20(21(19)23)22(24)25/h15,17-18,23H,2-14,16H2,1H3,(H,24,25)

Standard InChI Key:  HQVAQXLCHMEQLI-UHFFFAOYSA-N

Associated Targets(Human)

Small ubiquitin-related modifier 1 633 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 348.53Molecular Weight (Monoisotopic): 348.2664AlogP: 6.72#Rotatable Bonds: 15
Polar Surface Area: 57.53Molecular Species: ACIDHBA: 2HBD: 2
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 2.79CX Basic pKa: CX LogP: 8.71CX LogD: 5.22
Aromatic Rings: 1Heavy Atoms: 25QED Weighted: 0.35Np Likeness Score: 0.40

References

1. Brackett CM,García-Casas A,Castillo-Lluva S,Blagg BSJ.  (2020)  Synthesis and Evaluation of Ginkgolic Acid Derivatives as SUMOylation Inhibitors.,  11  (11): [PMID:33214832] [10.1021/acsmedchemlett.0c00353]

Source